NCT01353378

Brief Summary

The purpose of this study is to determine whether dexmedetomidine is effective in the treatment of emergence delirium of preschool children undergoing oral maxillofacial surgery.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2011

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2011

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 13, 2011

Completed
19 days until next milestone

Study Start

First participant enrolled

June 1, 2011

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

May 5, 2017

Status Verified

May 1, 2017

Enrollment Period

4 months

First QC Date

April 21, 2011

Last Update Submit

May 2, 2017

Conditions

Keywords

dexmedetomidineemergence deliriumsevoflurane anesthesiapreschool childrenoral maxillofacial surgery

Outcome Measures

Primary Outcomes (1)

  • post anesthesia emergence delirium scale(PAED scale)

    evaluate children's PAED scale score 2 hours post-surgery

    2 hours post-surgery

Secondary Outcomes (1)

  • Children's Hospital of Eastern Ontario Pain Scale(CHEOP scale)

    2 hours post-surgery

Study Arms (1)

dexmedetomidine

EXPERIMENTAL

intravenously injecting 0.125microgram/kg and 0.25microgram/kg within 10 minutes as soon as the operation begins respectively.

Drug: dexmedetomidine

Interventions

Intravenously injecting 0.125microgram/kg for 10ml IV(in the vein)in group 1, 0.25microgram/kg for 10ml in group 2 within 10 minutes as soon as the operation begin. The control group receives 10mlsaline in 10 minutes.

Also known as: dexmedetomidine hydrochloride injection
dexmedetomidine

Eligibility Criteria

Age3 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • preschool children undergoing oral maxillofacial surgery

You may not qualify if:

  • mental diseases
  • history of neural system disease
  • sedative medication history
  • anticipated difficult airway

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine

Shanghai, Shanghai Municipality, 200011, China

Location

MeSH Terms

Conditions

DeliriumEmergence Delirium

Interventions

Dexmedetomidine

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersPostoperative ComplicationsPathologic Processes

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Hong Jiang, MD, PHD

    Department of Anesthesiology, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine

    STUDY DIRECTOR
  • Rong Hu, MD

    Department of Anesthesiology, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 4
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
attending in anesthesiology department

Study Record Dates

First Submitted

April 21, 2011

First Posted

May 13, 2011

Study Start

June 1, 2011

Primary Completion

October 1, 2011

Study Completion

December 1, 2011

Last Updated

May 5, 2017

Record last verified: 2017-05

Locations